DOMAIN PARTERS VII L P Insider Trading Transactions
Get free email notifications about insider trading for DOMAIN PARTERS VII L P.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of DOMAIN PARTERS VII L P. DOMAIN PARTERS VII L P is 10% Owner in Achaogen Inc ($AKAO) and 10% Owner in Tobira Therapeutics, Inc. ($TBRA) and 10% Owner in CADENCE PHARMACEUTICALS INC ($CADX) and 10% Owner in ZOGENIX, INC. ($ZGNX) and 10% Owner in Orexigen Therapeutics, Inc. ($OREX) and 10% Owner in Evoke Pharma Inc ($EVOK) and 10% Owner in OBALON THERAPEUTICS INC ($OBLN) and 10% Owner in Esperion Therapeutics, Inc. ($ESPR) and 10% Owner in TANDEM DIABETES CARE INC ($TNDM) and 10% Owner in Clovis Oncology, Inc. ($CLVS) and 10% Owner in Neothetics, Inc. ($NEOT).
Latest Insider Trading Transactions of DOMAIN PARTERS VII L P
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AKAO, CADX, CLVS, ESPR, NEOT, EVOK, OREX, OBLN, TNDM, TBRA, ZGNX
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Aug 08 2019 | OBLN | OBALON THERAPEUTIC ... | DOMAIN PARTERS VII L P | 10% Owner | Option Exercise | P | 4.40 | 187,500 | 825,000 | 187,500 | |
Aug 08 2019 | OBLN | OBALON THERAPEUTIC ... | DOMAIN PARTERS VII L P | 10% Owner | Buy | P | 4.00 | 250,000 | 1,000,000 | 813,433 | 563.4 K to 813.4 K (+44.37 %) |
Aug 27 2018 | OBLN | OBALON THERAPEUTIC ... | DOMAIN PARTERS VII L P | 10% Owner | Buy | P | 1.82 | 1,648,359 | 3,000,013 | 5,634,329 | 4 M to 5.6 M (+41.35 %) |
Nov 03 2016 | TBRA | Tobira Therapeutic ... | DOMAIN PARTERS VII L P | 10% Owner | Sell | U | 28.35 | 3,553,322 | 100,736,679 | 0 | 3.6 M to 0 (-100.00 %) |
Oct 14 2016 | OBLN | OBALON THERAPEUTIC ... | DOMAIN PARTERS VII L P | 10% Owner | Option Exercise | C | 0.00 | 482,326 | 0 | 0 | |
Oct 14 2016 | OBLN | OBALON THERAPEUTIC ... | DOMAIN PARTERS VII L P | 10% Owner | Option Exercise | C | 0.00 | 597,207 | 0 | 0 | |
Oct 14 2016 | OBLN | OBALON THERAPEUTIC ... | DOMAIN PARTERS VII L P | 10% Owner | Option Exercise | C | 0.00 | 836,722 | 0 | 0 | |
Oct 14 2016 | OBLN | OBALON THERAPEUTIC ... | DOMAIN PARTERS VII L P | 10% Owner | Option Exercise | C | 0.00 | 1,206,836 | 0 | 0 | |
Oct 14 2016 | OBLN | OBALON THERAPEUTIC ... | DOMAIN PARTERS VII L P | 10% Owner | Option Exercise | C | 0.00 | 649,835 | 0 | 0 | |
Oct 14 2016 | OBLN | OBALON THERAPEUTIC ... | DOMAIN PARTERS VII L P | 10% Owner | Buy | C | 0.00 | 3,985,970 | 0 | 3,985,970 | 0 to 4 M |
May 27 2016 | EVOK | Evoke Pharma Inc | DOMAIN PARTERS VII L P | 10% Owner | Sell | S | 4.70 | 344,120 | 1,617,364 | 606,283 | 950.4 K to 606.3 K (-36.21 %) |
Apr 27 2016 | EVOK | Evoke Pharma Inc | DOMAIN PARTERS VII L P | 10% Owner | Sell | S | 5.02 | 3,603 | 18,087 | 950,403 | 954 K to 950.4 K (-0.38 %) |
Apr 27 2016 | EVOK | Evoke Pharma Inc | DOMAIN PARTERS VII L P | 10% Owner | Sell | S | 5.20 | 1,492 | 7,758 | 954,006 | 955.5 K to 954 K (-0.16 %) |
Apr 21 2016 | EVOK | Evoke Pharma Inc | DOMAIN PARTERS VII L P | 10% Owner | Sell | S | 5.29 | 4,424 | 23,403 | 955,498 | 959.9 K to 955.5 K (-0.46 %) |
Apr 21 2016 | EVOK | Evoke Pharma Inc | DOMAIN PARTERS VII L P | 10% Owner | Sell | S | 5.36 | 37,054 | 198,609 | 959,922 | 997 K to 959.9 K (-3.72 %) |
Apr 13 2016 | EVOK | Evoke Pharma Inc | DOMAIN PARTERS VII L P | 10% Owner | Sell | S | 5.22 | 4,348 | 22,697 | 996,976 | 1 M to 997 K (-0.43 %) |
Apr 08 2016 | EVOK | Evoke Pharma Inc | DOMAIN PARTERS VII L P | 10% Owner | Sell | S | 5.35 | 14,554 | 77,864 | 1,001,324 | 1 M to 1 M (-1.43 %) |
Apr 08 2016 | EVOK | Evoke Pharma Inc | DOMAIN PARTERS VII L P | 10% Owner | Sell | S | 5.26 | 27,781 | 146,128 | 1,015,878 | 1 M to 1 M (-2.66 %) |
Apr 08 2016 | EVOK | Evoke Pharma Inc | DOMAIN PARTERS VII L P | 10% Owner | Sell | S | 5.22 | 8,669 | 45,252 | 1,043,659 | 1.1 M to 1 M (-0.82 %) |
Aug 20 2015 | EVOK | Evoke Pharma Inc | DOMAIN PARTERS VII L P | 10% Owner | Sell | S | 7.02 | 11,836 | 83,089 | 1,052,328 | 1.1 M to 1.1 M (-1.11 %) |
May 06 2015 | TBRA | Tobira Therapeutic ... | DOMAIN PARTERS VII L P | 10% Owner | Buy | P | 10.62 | 277,777 | 2,949,992 | 3,553,322 | 3.3 M to 3.6 M (+8.48 %) |
Apr 16 2015 | EVOK | Evoke Pharma Inc | DOMAIN PARTERS VII L P | 10% Owner | Sell | S | 7.07 | 32,411 | 229,146 | 1,064,164 | 1.1 M to 1.1 M (-2.96 %) |
Apr 16 2015 | EVOK | Evoke Pharma Inc | DOMAIN PARTERS VII L P | 10% Owner | Sell | S | 7.58 | 7,920 | 60,034 | 1,096,575 | 1.1 M to 1.1 M (-0.72 %) |
Apr 16 2015 | EVOK | Evoke Pharma Inc | DOMAIN PARTERS VII L P | 10% Owner | Sell | S | 7.78 | 9,832 | 76,493 | 1,104,495 | 1.1 M to 1.1 M (-0.88 %) |
Mar 24 2015 | ESPR | Esperion Therapeut ... | DOMAIN PARTERS VII L P | 10% Owner | Sell | J | 0.00 | 350,000 | 0 | 2,216,935 | 2.6 M to 2.2 M (-13.63 %) |
Nov 26 2014 | NEOT | Neothetics, Inc. | DOMAIN PARTERS VII L P | 10% Owner | Option Exercise | M | 8.54 | 165,790 | 1,415,847 | 0 | |
Nov 26 2014 | NEOT | Neothetics, Inc. | DOMAIN PARTERS VII L P | 10% Owner | Option Exercise | M | 8.54 | 92,105 | 786,577 | 0 | |
Nov 26 2014 | NEOT | Neothetics, Inc. | DOMAIN PARTERS VII L P | 10% Owner | Option Exercise | C | 0.00 | 7,252,144 | 0 | 0 | |
Nov 26 2014 | NEOT | Neothetics, Inc. | DOMAIN PARTERS VII L P | 10% Owner | Option Exercise | C | 0.00 | 2,164,305 | 0 | 0 | |
Nov 26 2014 | NEOT | Neothetics, Inc. | DOMAIN PARTERS VII L P | 10% Owner | Option Exercise | C | 0.00 | 6,111,968 | 0 | 0 | |
Nov 26 2014 | NEOT | Neothetics, Inc. | DOMAIN PARTERS VII L P | 10% Owner | Option Exercise | C | 0.00 | 737,422 | 0 | 0 | |
Nov 26 2014 | NEOT | Neothetics, Inc. | DOMAIN PARTERS VII L P | 10% Owner | Buy | P | 14.00 | 70,000 | 980,000 | 3,091,642 | 3 M to 3.1 M (+2.32 %) |
Nov 26 2014 | NEOT | Neothetics, Inc. | DOMAIN PARTERS VII L P | 10% Owner | Payment of Exercise | F | 14.00 | 101,132 | 1,415,848 | 3,021,642 | 3.1 M to 3 M (-3.24 %) |
Nov 26 2014 | NEOT | Neothetics, Inc. | DOMAIN PARTERS VII L P | 10% Owner | Buy | M | 8.54 | 165,790 | 1,415,847 | 3,122,774 | 3 M to 3.1 M (+5.61 %) |
Nov 26 2014 | NEOT | Neothetics, Inc. | DOMAIN PARTERS VII L P | 10% Owner | Payment of Exercise | F | 14.00 | 56,185 | 786,590 | 2,956,984 | 3 M to 3 M (-1.86 %) |
Nov 26 2014 | NEOT | Neothetics, Inc. | DOMAIN PARTERS VII L P | 10% Owner | Buy | M | 8.54 | 92,105 | 786,577 | 3,013,169 | 2.9 M to 3 M (+3.15 %) |
Nov 26 2014 | NEOT | Neothetics, Inc. | DOMAIN PARTERS VII L P | 10% Owner | Buy | C | 0.00 | 2,921,064 | 0 | 2,921,064 | 0 to 2.9 M |
Oct 21 2014 | ESPR | Esperion Therapeut ... | DOMAIN PARTERS VII L P | 10% Owner | Buy | P | 20.00 | 500,000 | 10,000,000 | 2,566,935 | 2.1 M to 2.6 M (+24.19 %) |
Mar 21 2014 | CADX | CADENCE PHARMACEUT ... | DOMAIN PARTERS VII L P | 10% Owner | Sell | D | 14.00 | 2,972,678 | 41,617,492 | 0 | 3 M to 0 (-100.00 %) |
Feb 14 2014 | CADX | CADENCE PHARMACEUT ... | DOMAIN PARTERS VII L P | 10% Owner | Option Exercise | M | 7.84 | 1,367,020 | 10,717,437 | 0 | |
Feb 14 2014 | CADX | CADENCE PHARMACEUT ... | DOMAIN PARTERS VII L P | 10% Owner | Payment of Exercise | F | 14.00 | 765,532 | 10,717,448 | 2,972,678 | 3.7 M to 3 M (-20.48 %) |
Feb 14 2014 | CADX | CADENCE PHARMACEUT ... | DOMAIN PARTERS VII L P | 10% Owner | Buy | M | 7.84 | 1,367,020 | 10,717,437 | 3,738,210 | 2.4 M to 3.7 M (+57.65 %) |
Mar 17 2014 | AKAO | Achaogen Inc | DOMAIN PARTERS VII L P | 10% Owner | Option Exercise | C | 0.00 | 435,663 | 0 | 0 | |
Mar 17 2014 | AKAO | Achaogen Inc | DOMAIN PARTERS VII L P | 10% Owner | Option Exercise | C | 0.00 | 926,321 | 0 | 0 | |
Mar 17 2014 | AKAO | Achaogen Inc | DOMAIN PARTERS VII L P | 10% Owner | Option Exercise | C | 0.00 | 625,065 | 0 | 0 | |
Mar 17 2014 | AKAO | Achaogen Inc | DOMAIN PARTERS VII L P | 10% Owner | Buy | C | 0.00 | 1,987,049 | 0 | 1,987,049 | 0 to 2 M |
Nov 19 2013 | TNDM | TANDEM DIABETES CA ... | DOMAIN PARTERS VII L P | 10% Owner | Option Exercise | J | 7.37 | 352,351 | 2,596,827 | 352,351 | |
Nov 19 2013 | TNDM | TANDEM DIABETES CA ... | DOMAIN PARTERS VII L P | 10% Owner | Option Exercise | J | 4.40 | 590,403 | 2,597,773 | 0 | |
Nov 19 2013 | TNDM | TANDEM DIABETES CA ... | DOMAIN PARTERS VII L P | 10% Owner | Option Exercise | C | 0.00 | 2,283,114 | 0 | 0 | |
Nov 19 2013 | TNDM | TANDEM DIABETES CA ... | DOMAIN PARTERS VII L P | 10% Owner | Option Exercise | C | 0.00 | 549,833 | 0 | 0 | |
Nov 19 2013 | TNDM | TANDEM DIABETES CA ... | DOMAIN PARTERS VII L P | 10% Owner | Option Exercise | C | 0.00 | 356,111 | 0 | 0 | |
Nov 19 2013 | TNDM | TANDEM DIABETES CA ... | DOMAIN PARTERS VII L P | 10% Owner | Buy | C | 0.00 | 3,189,058 | 0 | 3,189,058 | 0 to 3.2 M |
Sep 30 2013 | EVOK | Evoke Pharma Inc | DOMAIN PARTERS VII L P | 10% Owner | Option Exercise | C | 0.00 | 1,114,327 | 0 | 0 | |
Sep 30 2013 | EVOK | Evoke Pharma Inc | DOMAIN PARTERS VII L P | 10% Owner | Buy | C | 0.00 | 1,114,327 | 0 | 1,114,327 | 0 to 1.1 M |
Jul 02 2013 | ESPR | Esperion Therapeut ... | DOMAIN PARTERS VII L P | 10% Owner | Option Exercise | J | 6.99 | 70,042 | 489,594 | 70,042 | |
Jul 02 2013 | ESPR | Esperion Therapeut ... | DOMAIN PARTERS VII L P | 10% Owner | Option Exercise | J | 1.00 | 489,320 | 489,320 | 0 | |
Jul 02 2013 | ESPR | Esperion Therapeut ... | DOMAIN PARTERS VII L P | 10% Owner | Option Exercise | C | 0.00 | 1,786,012 | 0 | 0 | |
Jul 02 2013 | ESPR | Esperion Therapeut ... | DOMAIN PARTERS VII L P | 10% Owner | Buy | P | 14.00 | 280,923 | 3,932,922 | 2,066,935 | 1.8 M to 2.1 M (+15.73 %) |
Jul 02 2013 | ESPR | Esperion Therapeut ... | DOMAIN PARTERS VII L P | 10% Owner | Buy | C | 0.00 | 1,786,012 | 0 | 1,786,012 | 0 to 1.8 M |
Jun 05 2013 | CLVS | Clovis Oncology, I ... | DOMAIN PARTERS VII L P | 10% Owner | Sell | S | 64.58 | 159,192 | 10,280,619 | 2,581,745 | 2.7 M to 2.6 M (-5.81 %) |
Apr 17 2013 | CADX | CADENCE PHARMACEUT ... | DOMAIN PARTERS VII L P | 10% Owner | Sell | S | 6.62 | 23,210 | 153,650 | 2,371,190 | 2.4 M to 2.4 M (-0.97 %) |
Apr 10 2013 | CADX | CADENCE PHARMACEUT ... | DOMAIN PARTERS VII L P | 10% Owner | Sell | S | 6.72 | 1,567 | 10,530 | 2,394,400 | 2.4 M to 2.4 M (-0.07 %) |
Apr 10 2013 | CADX | CADENCE PHARMACEUT ... | DOMAIN PARTERS VII L P | 10% Owner | Sell | S | 6.71 | 11,386 | 76,400 | 2,395,967 | 2.4 M to 2.4 M (-0.47 %) |
Apr 10 2013 | CADX | CADENCE PHARMACEUT ... | DOMAIN PARTERS VII L P | 10% Owner | Sell | S | 6.52 | 12,217 | 79,655 | 2,407,353 | 2.4 M to 2.4 M (-0.50 %) |
Mar 06 2013 | CLVS | Clovis Oncology, I ... | DOMAIN PARTERS VII L P | 10% Owner | Sell | S | 24.51 | 98,349 | 2,410,534 | 2,740,937 | 2.8 M to 2.7 M (-3.46 %) |
Mar 06 2013 | CLVS | Clovis Oncology, I ... | DOMAIN PARTERS VII L P | 10% Owner | Sell | S | 24.69 | 126,868 | 3,132,371 | 2,839,286 | 3 M to 2.8 M (-4.28 %) |
Mar 06 2013 | CLVS | Clovis Oncology, I ... | DOMAIN PARTERS VII L P | 10% Owner | Sell | S | 24.44 | 24,783 | 605,697 | 2,966,154 | 3 M to 3 M (-0.83 %) |
Mar 22 2013 | CADX | CADENCE PHARMACEUT ... | DOMAIN PARTERS VII L P | 10% Owner | Sell | S | 5.35 | 4,374 | 23,401 | 2,419,570 | 2.4 M to 2.4 M (-0.18 %) |
Mar 21 2013 | CADX | CADENCE PHARMACEUT ... | DOMAIN PARTERS VII L P | 10% Owner | Sell | S | 5.22 | 5,510 | 28,762 | 2,423,944 | 2.4 M to 2.4 M (-0.23 %) |
Mar 21 2013 | CADX | CADENCE PHARMACEUT ... | DOMAIN PARTERS VII L P | 10% Owner | Sell | S | 5.19 | 7,925 | 41,131 | 2,429,454 | 2.4 M to 2.4 M (-0.33 %) |
Mar 19 2013 | CADX | CADENCE PHARMACEUT ... | DOMAIN PARTERS VII L P | 10% Owner | Sell | S | 5.16 | 8,020 | 41,383 | 2,437,379 | 2.4 M to 2.4 M (-0.33 %) |
Mar 19 2013 | CADX | CADENCE PHARMACEUT ... | DOMAIN PARTERS VII L P | 10% Owner | Sell | S | 5.28 | 9,636 | 50,878 | 2,445,399 | 2.5 M to 2.4 M (-0.39 %) |
Mar 15 2013 | CADX | CADENCE PHARMACEUT ... | DOMAIN PARTERS VII L P | 10% Owner | Sell | S | 5.36 | 5,020 | 26,907 | 2,455,035 | 2.5 M to 2.5 M (-0.20 %) |
Mar 15 2013 | CADX | CADENCE PHARMACEUT ... | DOMAIN PARTERS VII L P | 10% Owner | Sell | S | 5.40 | 7,733 | 41,758 | 2,460,055 | 2.5 M to 2.5 M (-0.31 %) |
Mar 13 2013 | CADX | CADENCE PHARMACEUT ... | DOMAIN PARTERS VII L P | 10% Owner | Sell | S | 5.38 | 6,346 | 34,141 | 2,467,788 | 2.5 M to 2.5 M (-0.26 %) |
Mar 13 2013 | CADX | CADENCE PHARMACEUT ... | DOMAIN PARTERS VII L P | 10% Owner | Sell | S | 5.34 | 4,118 | 21,990 | 2,474,134 | 2.5 M to 2.5 M (-0.17 %) |
Mar 11 2013 | CADX | CADENCE PHARMACEUT ... | DOMAIN PARTERS VII L P | 10% Owner | Sell | S | 5.32 | 5,154 | 27,419 | 2,478,252 | 2.5 M to 2.5 M (-0.21 %) |
Mar 11 2013 | CADX | CADENCE PHARMACEUT ... | DOMAIN PARTERS VII L P | 10% Owner | Sell | S | 5.22 | 12,701 | 66,299 | 2,483,406 | 2.5 M to 2.5 M (-0.51 %) |
Mar 07 2013 | CADX | CADENCE PHARMACEUT ... | DOMAIN PARTERS VII L P | 10% Owner | Sell | S | 5.06 | 3,839 | 19,425 | 2,496,107 | 2.5 M to 2.5 M (-0.15 %) |
Mar 07 2013 | CADX | CADENCE PHARMACEUT ... | DOMAIN PARTERS VII L P | 10% Owner | Sell | S | 5.01 | 4,039 | 20,235 | 2,499,946 | 2.5 M to 2.5 M (-0.16 %) |
Mar 05 2013 | CADX | CADENCE PHARMACEUT ... | DOMAIN PARTERS VII L P | 10% Owner | Sell | S | 5.01 | 5,145 | 25,776 | 2,503,985 | 2.5 M to 2.5 M (-0.21 %) |
Mar 05 2013 | CADX | CADENCE PHARMACEUT ... | DOMAIN PARTERS VII L P | 10% Owner | Sell | S | 5.01 | 7,635 | 38,251 | 2,509,130 | 2.5 M to 2.5 M (-0.30 %) |
Feb 22 2013 | CADX | CADENCE PHARMACEUT ... | DOMAIN PARTERS VII L P | 10% Owner | Sell | S | 5.01 | 1,998 | 10,010 | 2,516,765 | 2.5 M to 2.5 M (-0.08 %) |
Feb 20 2013 | CADX | CADENCE PHARMACEUT ... | DOMAIN PARTERS VII L P | 10% Owner | Sell | S | 5.02 | 10,076 | 50,582 | 2,518,763 | 2.5 M to 2.5 M (-0.40 %) |
Feb 20 2013 | CADX | CADENCE PHARMACEUT ... | DOMAIN PARTERS VII L P | 10% Owner | Sell | S | 5.00 | 2,967 | 14,835 | 2,528,839 | 2.5 M to 2.5 M (-0.12 %) |
Feb 15 2013 | CADX | CADENCE PHARMACEUT ... | DOMAIN PARTERS VII L P | 10% Owner | Sell | S | 5.01 | 2,951 | 14,785 | 2,531,806 | 2.5 M to 2.5 M (-0.12 %) |
Feb 15 2013 | CADX | CADENCE PHARMACEUT ... | DOMAIN PARTERS VII L P | 10% Owner | Sell | S | 5.00 | 5,763 | 28,815 | 2,534,757 | 2.5 M to 2.5 M (-0.23 %) |
Feb 05 2013 | CADX | CADENCE PHARMACEUT ... | DOMAIN PARTERS VII L P | 10% Owner | Sell | S | 4.85 | 9,769 | 47,380 | 2,540,520 | 2.6 M to 2.5 M (-0.38 %) |
Feb 01 2013 | CADX | CADENCE PHARMACEUT ... | DOMAIN PARTERS VII L P | 10% Owner | Sell | S | 4.71 | 18,537 | 87,309 | 2,550,289 | 2.6 M to 2.6 M (-0.72 %) |
Feb 01 2013 | CADX | CADENCE PHARMACEUT ... | DOMAIN PARTERS VII L P | 10% Owner | Sell | S | 5.00 | 11,105 | 55,525 | 2,568,826 | 2.6 M to 2.6 M (-0.43 %) |
Jan 30 2013 | CADX | CADENCE PHARMACEUT ... | DOMAIN PARTERS VII L P | 10% Owner | Sell | S | 5.27 | 15,320 | 80,736 | 2,579,931 | 2.6 M to 2.6 M (-0.59 %) |
Jan 30 2013 | CADX | CADENCE PHARMACEUT ... | DOMAIN PARTERS VII L P | 10% Owner | Sell | S | 5.40 | 16,660 | 89,964 | 2,595,251 | 2.6 M to 2.6 M (-0.64 %) |
Jan 28 2013 | CADX | CADENCE PHARMACEUT ... | DOMAIN PARTERS VII L P | 10% Owner | Sell | S | 5.38 | 13,790 | 74,190 | 2,611,911 | 2.6 M to 2.6 M (-0.53 %) |
Jan 28 2013 | CADX | CADENCE PHARMACEUT ... | DOMAIN PARTERS VII L P | 10% Owner | Sell | S | 5.45 | 36,324 | 197,966 | 2,625,701 | 2.7 M to 2.6 M (-1.36 %) |
Jan 24 2013 | CADX | CADENCE PHARMACEUT ... | DOMAIN PARTERS VII L P | 10% Owner | Sell | S | 5.11 | 25,354 | 129,559 | 2,662,025 | 2.7 M to 2.7 M (-0.94 %) |
Jan 24 2013 | CADX | CADENCE PHARMACEUT ... | DOMAIN PARTERS VII L P | 10% Owner | Sell | S | 5.02 | 14,966 | 75,129 | 2,687,379 | 2.7 M to 2.7 M (-0.55 %) |
Jan 22 2013 | CADX | CADENCE PHARMACEUT ... | DOMAIN PARTERS VII L P | 10% Owner | Sell | S | 5.19 | 19,080 | 99,025 | 2,702,345 | 2.7 M to 2.7 M (-0.70 %) |
Jan 22 2013 | CADX | CADENCE PHARMACEUT ... | DOMAIN PARTERS VII L P | 10% Owner | Sell | S | 5.35 | 12,615 | 67,490 | 2,721,425 | 2.7 M to 2.7 M (-0.46 %) |
Jan 22 2013 | CADX | CADENCE PHARMACEUT ... | DOMAIN PARTERS VII L P | 10% Owner | Sell | S | 5.19 | 19,080 | 99,025 | 2,702,345 | 2.7 M to 2.7 M (-0.70 %) |
Jan 22 2013 | CADX | CADENCE PHARMACEUT ... | DOMAIN PARTERS VII L P | 10% Owner | Sell | S | 5.35 | 12,615 | 67,490 | 2,721,425 | 2.7 M to 2.7 M (-0.46 %) |
Dec 22 2011 | OREX | Orexigen Therapeut ... | DOMAIN PARTERS VII L P | 10% Owner | Option Exercise | P | 0.00 | 461,265 | 461 | 461,265 | |
Dec 22 2011 | OREX | Orexigen Therapeut ... | DOMAIN PARTERS VII L P | 10% Owner | Buy | P | 1.45 | 461,265 | 668,834 | 2,967,415 | 2.5 M to 3 M (+18.41 %) |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | DOMAIN PARTERS VII L P | 10% Owner | Option Exercise | C | 0.00 | 2,568,521 | 0 | 0 | |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | DOMAIN PARTERS VII L P | 10% Owner | Option Exercise | C | 0.00 | 1,186,657 | 0 | 0 | |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | DOMAIN PARTERS VII L P | 10% Owner | Option Exercise | C | 0.00 | 1,186,657 | 0 | 0 | |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | DOMAIN PARTERS VII L P | 10% Owner | Buy | P | 13.00 | 916,058 | 11,908,754 | 2,990,937 | 2.1 M to 3 M (+44.15 %) |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | DOMAIN PARTERS VII L P | 10% Owner | Buy | C | 0.00 | 370,799 | 0 | 2,074,879 | 1.7 M to 2.1 M (+21.76 %) |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | DOMAIN PARTERS VII L P | 10% Owner | Buy | C | 0.00 | 885,696 | 0 | 1,704,080 | 818.4 K to 1.7 M (+108.22 %) |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | DOMAIN PARTERS VII L P | 10% Owner | Buy | C | 0.00 | 409,192 | 0 | 818,384 | 409.2 K to 818.4 K (+100.00 %) |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | DOMAIN PARTERS VII L P | 10% Owner | Buy | C | 0.00 | 409,192 | 0 | 409,192 | 0 to 409.2 K |
Sep 20 2011 | ZGNX | ZOGENIX, INC. | DOMAIN PARTERS VII L P | 10% Owner | Buy | P | 2.00 | 3,441,304 | 6,882,608 | 9,923,335 | 6.5 M to 9.9 M (+53.09 %) |
Dec 01 2010 | ZGNX | ZOGENIX, INC. | DOMAIN PARTERS VII L P | 10% Owner | Option Exercise | C | 0.00 | 873,800 | 0 | 0 | |
Dec 01 2010 | ZGNX | ZOGENIX, INC. | DOMAIN PARTERS VII L P | 10% Owner | Option Exercise | C | 0.00 | 1,232,861 | 0 | 0 | |
Dec 01 2010 | ZGNX | ZOGENIX, INC. | DOMAIN PARTERS VII L P | 10% Owner | Option Exercise | C | 0.00 | 2,064,781 | 0 | 0 | |
Dec 01 2010 | ZGNX | ZOGENIX, INC. | DOMAIN PARTERS VII L P | 10% Owner | Buy | P | 4.00 | 2,310,589 | 9,242,356 | 6,482,031 | 4.2 M to 6.5 M (+55.39 %) |
Dec 01 2010 | ZGNX | ZOGENIX, INC. | DOMAIN PARTERS VII L P | 10% Owner | Buy | C | 0.00 | 873,800 | 0 | 4,171,442 | 3.3 M to 4.2 M (+26.50 %) |
Dec 01 2010 | ZGNX | ZOGENIX, INC. | DOMAIN PARTERS VII L P | 10% Owner | Buy | C | 0.00 | 1,232,861 | 0 | 3,297,642 | 2.1 M to 3.3 M (+59.71 %) |
Dec 01 2010 | ZGNX | ZOGENIX, INC. | DOMAIN PARTERS VII L P | 10% Owner | Buy | C | 0.00 | 2,064,781 | 0 | 2,064,781 | 0 to 2.1 M |
Dec 21 2009 | OREX | Orexigen Therapeut ... | DOMAIN PARTERS VII L P | 10% Owner | Buy | P | 7.50 | 37,461 | 280,958 | 2,506,150 | 2.5 M to 2.5 M (+1.52 %) |
Dec 21 2009 | OREX | Orexigen Therapeut ... | DOMAIN PARTERS VII L P | 10% Owner | Buy | P | 7.55 | 98,323 | 742,339 | 2,468,689 | 2.4 M to 2.5 M (+4.15 %) |
Nov 25 2009 | OREX | Orexigen Therapeut ... | DOMAIN PARTERS VII L P | 10% Owner | Buy | P | 6.75 | 49,161 | 331,837 | 2,370,366 | 2.3 M to 2.4 M (+2.12 %) |
Nov 24 2009 | OREX | Orexigen Therapeut ... | DOMAIN PARTERS VII L P | 10% Owner | Buy | P | 6.93 | 147,484 | 1,022,064 | 2,321,205 | 2.2 M to 2.3 M (+6.78 %) |
Nov 24 2009 | OREX | Orexigen Therapeut ... | DOMAIN PARTERS VII L P | 10% Owner | Buy | P | 6.93 | 245,808 | 1,703,449 | 2,173,721 | 1.9 M to 2.2 M (+12.75 %) |
Nov 16 2009 | OREX | Orexigen Therapeut ... | DOMAIN PARTERS VII L P | 10% Owner | Buy | P | 6.90 | 60,960 | 420,624 | 1,927,913 | 1.9 M to 1.9 M (+3.27 %) |
Nov 12 2009 | OREX | Orexigen Therapeut ... | DOMAIN PARTERS VII L P | 10% Owner | Buy | P | 6.93 | 52,701 | 365,218 | 1,866,953 | 1.8 M to 1.9 M (+2.90 %) |
Nov 12 2009 | OREX | Orexigen Therapeut ... | DOMAIN PARTERS VII L P | 10% Owner | Buy | P | 6.93 | 82,985 | 575,086 | 1,814,252 | 1.7 M to 1.8 M (+4.79 %) |
Aug 19 2009 | OREX | Orexigen Therapeut ... | DOMAIN PARTERS VII L P | 10% Owner | Buy | P | 7.73 | 13,553 | 104,765 | 1,731,267 | 1.7 M to 1.7 M (+0.79 %) |
Aug 18 2009 | OREX | Orexigen Therapeut ... | DOMAIN PARTERS VII L P | 10% Owner | Buy | P | 7.64 | 62,141 | 474,757 | 1,717,714 | 1.7 M to 1.7 M (+3.75 %) |
Aug 18 2009 | OREX | Orexigen Therapeut ... | DOMAIN PARTERS VII L P | 10% Owner | Buy | P | 8.00 | 25,785 | 206,280 | 1,655,573 | 1.6 M to 1.7 M (+1.58 %) |
Aug 14 2009 | OREX | Orexigen Therapeut ... | DOMAIN PARTERS VII L P | 10% Owner | Buy | P | 7.85 | 12,782 | 100,339 | 1,629,788 | 1.6 M to 1.6 M (+0.79 %) |
Aug 14 2009 | OREX | Orexigen Therapeut ... | DOMAIN PARTERS VII L P | 10% Owner | Buy | P | 8.00 | 393,292 | 3,146,336 | 1,617,006 | 1.2 M to 1.6 M (+32.14 %) |
Aug 13 2009 | OREX | Orexigen Therapeut ... | DOMAIN PARTERS VII L P | 10% Owner | Buy | P | 7.60 | 102,551 | 779,388 | 1,223,714 | 1.1 M to 1.2 M (+9.15 %) |
Jul 24 2009 | OREX | Orexigen Therapeut ... | DOMAIN PARTERS VII L P | 10% Owner | Buy | P | 7.50 | 639,099 | 4,793,243 | 1,121,163 | 482.1 K to 1.1 M (+132.58 %) |
Dec 11 2008 | OREX | Orexigen Therapeut ... | DOMAIN PARTERS VII L P | 10% Owner | Buy | P | 4.93 | 237,826 | 1,172,482 | 482,064 | 244.2 K to 482.1 K (+97.37 %) |
Page: 1